ISRG · 8-K · 20261020PR000067

Operating Expense Trends

INTUITIVE SURGICAL INC · 2026-10-20 · Importance 77 · Surprise 82 · From source text

Third-quarter operating expenses increased 65% year over year to $1.49 billion from $903 million. Selling, general, and administrative expense increased to $1.08 billion from $573 million, primarily because of the $454.9 million antitrust litigation charge. Research and development expense increased 24% to $408 million from $329 million. Share-based compensation expense increased to $216 million from $206 million, including $212.6 million in operating expense reconciliation adjustments.

Key facts

• Selling, general, and administrative expenses for Q3 2026 were $1,083.4 million, which included litigation charges of $454.9 million. source
• Nine months ended September 30, 2026 selling, general, and administrative expense was $2,314.6 million, which included litigation charges of $461.3 million year-to-date. source
• Q3 2026 selling, general, and administrative expense increased to $1,083.4 million from $573.3 million in Q3 2025. source
• Q3 2026 research and development expense was $408.3 million, compared with $329.4 million in Q3 2025. source
• Third quarter 2026 GAAP income from operations included share-based compensation expense of $216 million, compared with $206 million in Q3 2025. source
• The Company excluded items such as amortization of intangible assets, share-based compensation and LTIP expenses, acquisition-related items, a facilities asset abandonment charge, litigation charges, and gains on sales of businesses and assets from its non-GAAP measures. source

Impact estimates